Tianjin Tianyao Pharmaceuticals Co., Ltd.SSE: 600488

Announcement on Outline of the Q3 2025 Performance Briefing

· Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

The briefing took place via an online interactive format on a specified date. Company executives discussed financial status, market expansion, and future strategies with investors. The company addressed investor questions regarding market trends and product developments during the session. This filing serves to inform stakeholders about the performance briefing and its outcomes.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix

Earlier from Tianjin Tianyao Pharmaceuticals

Later from Tianjin Tianyao Pharmaceuticals

All Tianjin Tianyao Pharmaceuticals news releases